Dimensional Fund Advisors LP Increases Stake in OrthoPediatrics Corp. (NASDAQ:KIDS)

Dimensional Fund Advisors LP increased its holdings in OrthoPediatrics Corp. (NASDAQ:KIDS – Get Rating) by 9.5% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 327,406 shares of the company’s stock after purchasing an additional 28,409 shares during the period. Dimensional Fund Advisors LP owned approximately 1.43% of OrthoPediatrics worth $15,108,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in KIDS. Legal & General Group Plc raised its holdings in OrthoPediatrics by 5.0% in the 2nd quarter. Legal & General Group Plc now owns 4,878 shares of the company’s stock worth $210,000 after purchasing an additional 233 shares in the last quarter. HighTower Advisors LLC raised its holdings in OrthoPediatrics by 3.5% in the 1st quarter. HighTower Advisors LLC now owns 11,874 shares of the company’s stock worth $643,000 after purchasing an additional 400 shares in the last quarter. Point72 Hong Kong Ltd bought a new position in OrthoPediatrics in the 1st quarter worth $26,000. MCF Advisors LLC bought a new position in OrthoPediatrics in the 3rd quarter worth $33,000. Finally, Envestnet Asset Management Inc. raised its holdings in OrthoPediatrics by 1.6% in the 2nd quarter. Envestnet Asset Management Inc. now owns 48,017 shares of the company’s stock worth $2,072,000 after purchasing an additional 755 shares in the last quarter. Hedge funds and other institutional investors own 97.02% of the company’s stock.

Insider Activity at OrthoPediatrics

In related news, EVP Gregory A. Odle sold 1,195 shares of the stock in a transaction dated Thursday, February 2nd. The shares were sold at an average price of $50.00, for a total transaction of $59,750.00. Following the sale, the executive vice president now directly owns 71,850 shares of the company’s stock, valued at approximately $3,592,500. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, SVP Joseph W. Hauser sold 2,554 shares of the firm’s stock in a transaction dated Thursday, March 2nd. The shares were sold at an average price of $43.74, for a total transaction of $111,711.96. Following the sale, the senior vice president now owns 36,144 shares of the company’s stock, valued at approximately $1,580,938.56. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Gregory A. Odle sold 1,195 shares of the firm’s stock in a transaction dated Thursday, February 2nd. The shares were sold at an average price of $50.00, for a total transaction of $59,750.00. Following the sale, the executive vice president now directly owns 71,850 shares in the company, valued at approximately $3,592,500. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 25,231 shares of company stock valued at $1,120,988. 29.50% of the stock is owned by insiders.

OrthoPediatrics Stock Performance

Shares of KIDS stock opened at $41.50 on Thursday. OrthoPediatrics Corp. has a one year low of $35.67 and a one year high of $60.75. The company’s 50-day moving average is $44.73 and its 200 day moving average is $44.38. The company has a market capitalization of $954.09 million, a price-to-earnings ratio of 1,383.79 and a beta of 0.91.

Wall Street Analysts Forecast Growth

Several brokerages have commented on KIDS. Truist Financial upped their price objective on shares of OrthoPediatrics from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Tuesday, January 31st. Needham & Company LLC increased their price target on shares of OrthoPediatrics from $50.00 to $51.00 and gave the stock a “buy” rating in a research note on Wednesday, March 1st. TheStreet lowered shares of OrthoPediatrics from a “c” rating to a “d+” rating in a research note on Wednesday, March 1st. Finally, Stifel Nicolaus decreased their price target on shares of OrthoPediatrics from $52.00 to $50.00 and set a “buy” rating for the company in a research note on Tuesday, January 10th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $55.17.

About OrthoPediatrics

(Get Rating)

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. It offers products relating to trauma and deformity, scoliosis, and sports medicine and other procedures. The company was founded by Erin Springer Yount and Nick A.